Role and Regulation of TSLP in Childhood Allergic Disease

TSLP在儿童过敏性疾病中的作用和调节

基本信息

项目摘要

Project Summary A recent international workshop convened to review the findings from asthma/allergy birth cohorts and identify knowledge gaps and research priorities. In their summary, they conclude that a key research priority need is to better understand the mechanisms of progression to asthma in early childhood. This proposal will help to fill this critical gap in understanding. Thymic stromal lymphopoietin (TSLP) is a major epithelial cytokine that and is strongly implicated in the pathogenesis of AD, allergic sensitization, and asthma. Antigen exposure in the skin in the context of TSLP is sufficient to induce AD and airway inflammation in the lung, suggesting that skin-derived TSLP is sufficient to drive the progression of AD to asthma. TSLP single nucleotide polymorphisms (SNPs) have been associated with allergic sensitization and asthma, as well as AD. Expression of TSLP is increased in AD and disease-associated eQTL in TSLP correlate with TSLP expression. These studies collectively suggest TSLP promotes allergic sensitization and AD in early life and may be an important driver of progression of a subset of early allergic phenotypes to asthma. Despite the increasingly evident role of TSLP in allergic disease, the mechanisms by which TSLP is induced in human skin remain unclear. We recently found that among the known TSLP SNPs, 25% disrupt or create a new CpG site, which is significantly higher than the frequency of CpG- SNPs across the genome, and the prevalence of CpG-SNPs is even higher among TSLP SNPs that have been associated with allergic disorders. We have recently identified candidate enhancers upstream of the TSLP locus that may drive TSLP expression and found that allergic disease-associated TSLP SNPs, including eQTL, reside or are in strong linkage disequilibrium with these candidate enhancers. Based on our preliminary data, we hypothesize that mechanical stress and/or barrier dysfunction are translated to TSLP expression through dedicated enhancers and that genetic variation in the TSLP locus relaxes this regulation resulting in enhanced TSLP expression and clinical progression to asthma. This application will have significant public health impact. Through the proposed aims, we will (1) elucidate the mechanisms by which barrier defects in human epidermal keratinocytes are sensed and translated to TSLP transcription; (2) delineate the impact of known risk and protective alleles on this regulation; (3) determine the utility of genetic and epigenetic variation in the TSLP locus as biomarkers of disease progression to asthma; and (4) provide the foundation for development of new algorithms to accurately predict the development of asthma among preschool aged children.
项目摘要 最近召开的一次国际研讨会审查了哮喘/过敏症出生队列的发现, 知识差距和研究重点。在他们的总结中,他们得出结论,一个关键的研究优先需要是 更好地了解儿童早期哮喘进展的机制。该提案将有助于填补这一 理解上的巨大差距。胸腺基质淋巴细胞生成素(TSLP)是一种主要的上皮细胞因子, 与AD、过敏性致敏和哮喘的发病机制密切相关。皮肤中的抗原暴露 在TSLP的情况下,足以诱导AD和肺部气道炎症,这表明皮肤来源的 TSLP足以促使AD进展为哮喘。TSLP单核苷酸多态性(SNP)具有 与过敏性致敏和哮喘以及AD相关。AD患者TSLP表达增加 TSLP中的疾病相关eQTL与TSLP表达相关。这些研究共同表明TSLP 在生命早期促进过敏性致敏和AD,可能是一个重要的驱动因素, 哮喘的早期过敏表型。尽管TSLP在过敏性疾病中的作用越来越明显, 在人皮肤中诱导TSLP的机制仍不清楚。我们最近发现, TSLP SNPs,25%破坏或创建新的CpG位点,这显著高于CpG位点的频率。 在基因组中的SNP,CpG-SNP的流行率甚至更高的TSLP SNP中, 与过敏性疾病有关。我们最近已经确定了TSLP基因座上游的候选增强子 这可能驱动TSLP表达,并发现过敏性疾病相关的TSLP SNP,包括eQTL, 或者与这些候选增强子处于强连锁不平衡。根据初步数据,我们 假设机械应力和/或屏障功能障碍通过 TSLP基因座中的遗传变异放松了这种调节,导致增强的 TSLP表达与哮喘临床进展这一应用将对公共卫生产生重大影响。 通过提出的目标,我们将(1)阐明人表皮屏障缺陷的机制, 角质形成细胞被感知并翻译成TSLP转录;(2)描述已知风险的影响, 保护等位基因的调节;(3)确定TSLP基因座的遗传和表观遗传变异的效用 作为疾病进展为哮喘的生物标志物;和(4)为开发新的 准确预测学龄前儿童哮喘发展的算法。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Analysis of chromatin accessibility in human epidermis identifies putative barrier dysfunction-sensing enhancers.
  • DOI:
    10.1371/journal.pone.0184500
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Lander JM;Supp DM;He H;Martin LJ;Chen X;Weirauch MT;Boyce ST;Kopan R
  • 通讯作者:
    Kopan R
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gurjit K. Khurana Hershey其他文献

Frequent exacerbator—a novel endotype of pediatric asthma
  • DOI:
    10.1016/j.jaci.2025.05.006
  • 发表时间:
    2025-07-01
  • 期刊:
  • 影响因子:
    11.200
  • 作者:
    Kieran J. Phelan;Gurjit K. Khurana Hershey
  • 通讯作者:
    Gurjit K. Khurana Hershey
emTSLP/em disease-associated genetic variants combined with airway TSLP expression influence asthma risk
  • DOI:
    10.1016/j.jaci.2021.05.033
  • 发表时间:
    2022-01-01
  • 期刊:
  • 影响因子:
    11.200
  • 作者:
    Liza Bronner Murrison;Xiaomeng Ren;Kristina Preusse;Hua He;John Kroner;Xiaoting Chen;Seth Jenkins;Elisabet Johansson;Jocelyn M. Biagini;Matthew T. Weirauch;Raphael Kopan;Lisa J. Martin;Gurjit K. Khurana Hershey
  • 通讯作者:
    Gurjit K. Khurana Hershey
Rhinoconjunctivitis symptoms in children and adolescents with asthma: Longitudinal clustering analysis
哮喘儿童和青少年的鼻结膜炎症状:纵向聚类分析
  • DOI:
    10.1016/j.jaci.2024.12.1084
  • 发表时间:
    2025-05-01
  • 期刊:
  • 影响因子:
    11.200
  • 作者:
    Alkis Togias;Peter J. Gergen;Andrew H. Liu;Haejin Kim;Robert A. Wood;George T. O’Connor;Melanie Makhija;Gurjit K. Khurana Hershey;Carolyn M. Kercsmar;Rebecca S. Gruchalla;Carin Lamm;Leonard B. Bacharier;Shilpa J. Patel;James E. Gern;Daniel J. Jackson;Cynthia M. Visness;Agustin Calatroni;William W. Busse
  • 通讯作者:
    William W. Busse
Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop
针对过敏性疾病和哮喘的生物标志物驱动的药物开发:FDA 公共研讨会
  • DOI:
    10.1016/j.jaci.2025.03.014
  • 发表时间:
    2025-06-01
  • 期刊:
  • 影响因子:
    11.200
  • 作者:
    Ronald L. Rabin;Matthew C. Altman;S. Hasan Arshad;Richard D. Beger;Pamela A. Frischmeyer-Guerrerio;Elena Goleva;Robert G. Hamilton;Gurjit K. Khurana Hershey;Mohamed H. Shamji;Hugh A. Sampson;Alexandra F. Santos;Wayne G. Shreffler;Alkis Togias;Stefan Vieths;Erik Wambre;Sally E. Wenzel;Kathleen Hise;Joohee Lee;Anubha Tripathi;Jay E. Slater
  • 通讯作者:
    Jay E. Slater
High number of early respiratory infections in association with allergic sensitization to mold promotes childhood asthma
  • DOI:
    10.1016/j.jaci.2017.11.058
  • 发表时间:
    2018-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Leilanie Perez Ramirez;Heepke Wendroth;Lisa J. Martin;Valentina V. Pilipenko;Hua He;John Kroner;Patrick H. Ryan;Grace K. LeMasters;James E. Lockey;David I. Bernstein;Gurjit K. Khurana Hershey;Jocelyn M. Biagini Myers
  • 通讯作者:
    Jocelyn M. Biagini Myers

Gurjit K. Khurana Hershey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gurjit K. Khurana Hershey', 18)}}的其他基金

Medical Scientist Training Program
医学科学家培训计划
  • 批准号:
    10620999
  • 财政年份:
    2023
  • 资助金额:
    $ 73.07万
  • 项目类别:
Multi-omics of the Frequent Exacerbator Asthmatic
频繁加重哮喘的多组学
  • 批准号:
    10197294
  • 财政年份:
    2021
  • 资助金额:
    $ 73.07万
  • 项目类别:
Multi-omics of the Frequent Exacerbator Asthmatic
频繁加重哮喘的多组学
  • 批准号:
    10596089
  • 财政年份:
    2021
  • 资助金额:
    $ 73.07万
  • 项目类别:
Multi-omics of the Frequent Exacerbator Asthmatic
频繁加重哮喘的多组学
  • 批准号:
    10390405
  • 财政年份:
    2021
  • 资助金额:
    $ 73.07万
  • 项目类别:
Atopic dermatitis: mechanisms of disease progression
特应性皮炎:疾病进展的机制
  • 批准号:
    10379962
  • 财政年份:
    2020
  • 资助金额:
    $ 73.07万
  • 项目类别:
Atopic dermatitis: mechanisms of disease progression
特应性皮炎:疾病进展的机制
  • 批准号:
    10596577
  • 财政年份:
    2020
  • 资助金额:
    $ 73.07万
  • 项目类别:
Atopic dermatitis: mechanisms of disease progression
特应性皮炎:疾病进展的机制
  • 批准号:
    9974832
  • 财政年份:
    2020
  • 资助金额:
    $ 73.07万
  • 项目类别:
Role and Regulation of TSLP in Childhood Allergic Disease
TSLP在儿童过敏性疾病中的作用和调节
  • 批准号:
    10063471
  • 财政年份:
    2017
  • 资助金额:
    $ 73.07万
  • 项目类别:
Infrastructure and Opportunity Fund Management
基础设施和机会基金管理
  • 批准号:
    8329216
  • 财政年份:
    2011
  • 资助金额:
    $ 73.07万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8196249
  • 财政年份:
    2011
  • 资助金额:
    $ 73.07万
  • 项目类别:

相似海外基金

DMS-EPSRC: Asymptotic Analysis of Online Training Algorithms in Machine Learning: Recurrent, Graphical, and Deep Neural Networks
DMS-EPSRC:机器学习中在线训练算法的渐近分析:循环、图形和深度神经网络
  • 批准号:
    EP/Y029089/1
  • 财政年份:
    2024
  • 资助金额:
    $ 73.07万
  • 项目类别:
    Research Grant
CAREER: Blessing of Nonconvexity in Machine Learning - Landscape Analysis and Efficient Algorithms
职业:机器学习中非凸性的祝福 - 景观分析和高效算法
  • 批准号:
    2337776
  • 财政年份:
    2024
  • 资助金额:
    $ 73.07万
  • 项目类别:
    Continuing Grant
CAREER: From Dynamic Algorithms to Fast Optimization and Back
职业:从动态算法到快速优化并返回
  • 批准号:
    2338816
  • 财政年份:
    2024
  • 资助金额:
    $ 73.07万
  • 项目类别:
    Continuing Grant
CAREER: Structured Minimax Optimization: Theory, Algorithms, and Applications in Robust Learning
职业:结构化极小极大优化:稳健学习中的理论、算法和应用
  • 批准号:
    2338846
  • 财政年份:
    2024
  • 资助金额:
    $ 73.07万
  • 项目类别:
    Continuing Grant
CRII: SaTC: Reliable Hardware Architectures Against Side-Channel Attacks for Post-Quantum Cryptographic Algorithms
CRII:SaTC:针对后量子密码算法的侧通道攻击的可靠硬件架构
  • 批准号:
    2348261
  • 财政年份:
    2024
  • 资助金额:
    $ 73.07万
  • 项目类别:
    Standard Grant
CRII: AF: The Impact of Knowledge on the Performance of Distributed Algorithms
CRII:AF:知识对分布式算法性能的影响
  • 批准号:
    2348346
  • 财政年份:
    2024
  • 资助金额:
    $ 73.07万
  • 项目类别:
    Standard Grant
CRII: CSR: From Bloom Filters to Noise Reduction Streaming Algorithms
CRII:CSR:从布隆过滤器到降噪流算法
  • 批准号:
    2348457
  • 财政年份:
    2024
  • 资助金额:
    $ 73.07万
  • 项目类别:
    Standard Grant
EAGER: Search-Accelerated Markov Chain Monte Carlo Algorithms for Bayesian Neural Networks and Trillion-Dimensional Problems
EAGER:贝叶斯神经网络和万亿维问题的搜索加速马尔可夫链蒙特卡罗算法
  • 批准号:
    2404989
  • 财政年份:
    2024
  • 资助金额:
    $ 73.07万
  • 项目类别:
    Standard Grant
CAREER: Efficient Algorithms for Modern Computer Architecture
职业:现代计算机架构的高效算法
  • 批准号:
    2339310
  • 财政年份:
    2024
  • 资助金额:
    $ 73.07万
  • 项目类别:
    Continuing Grant
CAREER: Improving Real-world Performance of AI Biosignal Algorithms
职业:提高人工智能生物信号算法的实际性能
  • 批准号:
    2339669
  • 财政年份:
    2024
  • 资助金额:
    $ 73.07万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了